These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Comparative Study of Inhaler Device Handling Technique and Risk Factors for Critical Inhaler Errors in Korean COPD Patients. Jang JG, Chung JH, Shin KC, Jin HJ, Lee KH, Ahn JH. Int J Chron Obstruct Pulmon Dis; 2021; 16():1051-1059. PubMed ID: 33907392 [Abstract] [Full Text] [Related]
29. Device errors in asthma and COPD: systematic literature review and meta-analysis. Chrystyn H, van der Palen J, Sharma R, Barnes N, Delafont B, Mahajan A, Thomas M. NPJ Prim Care Respir Med; 2017 Apr 03; 27(1):22. PubMed ID: 28373682 [Abstract] [Full Text] [Related]
35. [Persistence to treatment by type of inhaler device in patients with asthma and chronic obstructive pulmonary disease]. Sicras A, Ferrer V, Collar JM, Navarro R, Sáez M. Semergen; 2017 Apr 03; 43(5):375-386. PubMed ID: 27425817 [Abstract] [Full Text] [Related]
36. Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover study. Singh D, Ciurlia G, Piccinno A, Muraro A, Bocchi M, Scuri M. Pulm Pharmacol Ther; 2017 Feb 03; 42():43-51. PubMed ID: 28065679 [Abstract] [Full Text] [Related]
37. A review of the development of Respimat Soft Mist Inhaler. Dalby R, Spallek M, Voshaar T. Int J Pharm; 2004 Sep 28; 283(1-2):1-9. PubMed ID: 15363496 [Abstract] [Full Text] [Related]
38. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler. Hodder R, Price D. Int J Chron Obstruct Pulmon Dis; 2009 Sep 28; 4():381-90. PubMed ID: 19888356 [Abstract] [Full Text] [Related]
39. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Nannini L, Cates CJ, Lasserson TJ, Poole P. Cochrane Database Syst Rev; 2004 Sep 28; (3):CD003794. PubMed ID: 15266502 [Abstract] [Full Text] [Related]
40. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study. Jones R, Martin J, Thomas V, Skinner D, Marshall J, Stagno d'Alcontres M, Price D. Int J Chron Obstruct Pulmon Dis; 2017 Sep 28; 12():2445-2454. PubMed ID: 28860739 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]